Crowdonomics
WatchlistPortfolio
Potion Adaptogenic Brews

Reg CF · Common Stock · Jun 2022

WithdrawnReached targetReg CFCommon Equity
via StartEngineView campaign
Raised
$88.1K / $1.1M max
8% of ceiling · target hit day 6
Investors
25
$3.5K avg
Post-money valuation
$5.1M
pre-money + amount raised

Raised over time

Cumulative raisedInvestors
$88K$44K$0
25130
Jun 7, 2022 · openedJul 22, 2022 · last reading
Target ($10K) hit — Jun 13, 2022, day 6Deadline Sep 9, 2022 — 49 days out

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via StartEngine; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2020–FY2021 · hover for source
$0
FY2020
$5K
−$14K
FY2021
RevenueNet income
Metric
FY2020 reviewed
FY2021 reviewed
Income statement
Revenue
$0
$5,109
Cost of goods sold
$0
$2,239
Gross margin
—
56%
Net income
$0
-$13,872
Taxes paid
$0
$0
Balance sheet
Cash
$0
$7,742
Accounts receivable
$0
$5,069
Total assets
$0
$61,551
Short-term debt
$0
$75,338
Long-term debt
$0
$0
Total liabilities
$0
$75,338
Other
Headcount
—
2

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Pre-money$5M
Post-money$5.1M
Price / share$1.00
Shares offered10,000

Perks

Invest within the first week and receive 15% bonus shares · until Jun 13, 202215% bonus

Offering details

Target$10,000
Max$1,070,000
Min investment$200
OpenedJun 7, 2022
DeadlineSep 9, 2022
ClosedAug 1, 2022
Days active55

Links & provenance

Campaign pageSEC filing
Source: Manual
0001665160-22-001776

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.